MeVox
Protection by design
London, United Kingdom · Founded 2020 · $6.1M raised
- Headquarters
- London
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2B
- Website
- mevoxltd.com
- Total Funding
- $6.1M
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.
About
Biotech company developing conformationally precise vaccines using cutting-edge antigen design and molecular engineering.
Summary
MeVox is a Biotech company based in London, United Kingdom, founded in 2020. It has raised $6.1M in total across 1 round. Investors include Morningside Group.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/mevox"><img src="https://indexed.vc/api/badge/company/mevox" alt="MeVox on Indexed.vc" width="260" height="76" /></a>